Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women

被引：0
|
作者：
M. Chandran
G. Ganesan
K.B. Tan
J.-Y. Reginster
M. Hiligsmann
机构：
[1] Singapore General Hospital,Osteoporosis and Bone Metabolism Unit, Department of Endocrinology
[2] Ministry of Health,School of Public Health
[3] National University of Singapore,Center for Investigation in Bone and Articular Cartilage
[4] University of Liege,Department of Health Services Research, CAPHRI Care and Public Health Research Institute
[5] Maastricht University,undefined
来源：
Osteoporosis International | 2021年 / 32卷
关键词：
Alendronate; Cost-effectiveness analysis; FRAX; Intervention thresholds; Osteoporosis; Singapore;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：133 / 144
页数：11
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF FRAX® BASED INTERVENTION THRESHOLDS FOR MANAGEMENT OF OSTEOPOROSIS IN SINGAPOREAN WOMEN
    Chandran, M.
    Ganesan, G.
    Tan, K. B.
    Reginster, J. Y.
    Yong, E. L.
    Hiligsmann, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S459 - S459
  • [2] Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
    Chandran, M.
    Ganesan, G.
    Tan, K. B.
    Reginster, J-Y
    Hiligsmann, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 133 - 144
  • [3] FRAX® based intervention thresholds for management of osteoporosis in Singaporean women
    Chandran, M.
    McCloskey, E. V.
    Thu, W. P. P.
    Logan, S.
    Hao, Y.
    Tay, D.
    Ang, W. C.
    Aung, T. K. K.
    Choo, K. S.
    Ali, A.
    Yan, S. X.
    Huang, X. F.
    Liu, X. M.
    Yong, E. L.
    Lekamwasam, S.
    [J]. ARCHIVES OF OSTEOPOROSIS, 2018, 13 (01)
  • [4] FRAX® based intervention thresholds for management of osteoporosis in Singaporean women
    M. Chandran
    E. V. McCloskey
    W. P. P. Thu
    S. Logan
    Y. Hao
    D. Tay
    W. C. Ang
    T. K. K. Aung
    K. S. Choo
    A. Ali
    S. X. Yan
    X. F. Huang
    X. M. Liu
    E. L. Yong
    S. Lekamwasam
    [J]. Archives of Osteoporosis, 2018, 13
  • [5] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Andréa Marques
    Óscar Lourenço
    Gustaf Ortsäter
    Fredrik Borgström
    John A. Kanis
    José António P. da Silva
    [J]. Calcified Tissue International, 2016, 99 : 131 - 141
  • [6] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Marques, Andrea
    Lourenco, Oscar
    Ortsater, Gustaf
    Borgstrom, Fredrik
    Kanis, John A.
    da Silva, Jose Antnio P.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2016, 99 (02) : 131 - 141
  • [7] Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAX™ thresholds for decision
    Alzahouri, Kazem
    Bahrami, Stephane
    Durand-Zaleski, Isabelle
    Guillemin, Francis
    Roux, Christian
    [J]. JOINT BONE SPINE, 2013, 80 (01) : 64 - 69
  • [8] Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
    O. Ström
    B. Jönsson
    J. A. Kanis
    [J]. Osteoporosis International, 2013, 24 : 1491 - 1502
  • [9] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
    F. Borgström
    O. Ström
    J. Coelho
    H. Johansson
    A. Oden
    E. V. McCloskey
    J. A. Kanis
    [J]. Osteoporosis International, 2010, 21 : 495 - 505
  • [10] PREDICTING THE INTERVENTION THRESHOLD FOR TREATING OSTEOPOROSIS AMONG POSTMENOPAUSAL WOMEN IN CHINA: A COST-EFFECTIVENESS ANALYSIS BASED ON FRAX
    Cui, L.
    He, T.
    Jiang, Y.
    Li, M.
    Wang, O.
    Xing, X.
    Xia, W.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S321 - S321
12345